Predicting drug response of tumors from integrated genomic profiles by deep neural networks

BACKGROUND: The study of high-throughput genomic profiles from a pharmacogenomics viewpoint has provided unprecedented insights into the oncogenic features modulating drug response. A recent study screened for the response of a thousand human cancer cell lines to a wide collection of anti-cancer dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Yu-Chiao, Chen, Hung-I Harry, Zhang, Tinghe, Zhang, Songyao, Gorthi, Aparna, Wang, Li-Ju, Huang, Yufei, Chen, Yidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357352/
https://www.ncbi.nlm.nih.gov/pubmed/30704458
http://dx.doi.org/10.1186/s12920-018-0460-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357352/
https://www.ncbi.nlm.nih.gov/pubmed/30704458
http://dx.doi.org/10.1186/s12920-018-0460-9

Ejemplares similares